Find the right partners. Close the right deals.
JustPartnering helps biotech and research teams identify, position, and license their assets to the right pharma and biotech partners.
We find who is actively in-licensing in your space, prepare the materials they need to see, and keep every conversation moving until terms are agreed.
- Pitch development
- Target identification
- Strategic outreach
The network behind the work
- 4,000+
- Business development contacts mapped
- 2,500+
- In-licensing companies tracked
- 300+
- Face-to-face meetings a year
Across pharma, biotech & animal health, globally.
Mapped by therapeutic area, modality & stage.
Plus many more held virtually.
We become your BD function, without the overhead of hiring one.
A biotech BD consultant helps life sciences companies identify potential licensing partners, develop pitch materials, manage outreach, and negotiate deal terms. JustPartnering provides end-to-end business development and licensing support for biotech and research teams, from target list to signed agreement. Our hourly model has no retainer, success fee, or minimum commitment, so our advice stays focused on getting you the right deal.
Know which partners you should be talking to?
Most teams don't. We can show you who is actively in-licensing in your space, and what it takes to reach them.
How we get your asset in front of the right partners
From positioning through to signed deal, we support every stage of the partnering process.
- 1
Target identification
- 2
Pitch development
- 3
Outreach & introductions
- 4
Conference support
- 5
Deal management
Identify the right partners
Receive a prioritised target list of in-licensing companies, filtered to fit your asset.
- Includes contact names, job titles, and email addresses, ready to action
- A broad list of all potential partners in your partnering universe
- Delivered as a working document for independent use, or with our support
Most curated target lists cost US$700–$2,000, ready within 3 days
Contains a ranked list of companies in-licensing assets in your therapeutic area or disease indication and at your stage of development.
Get a target listBuild a partner-ready pitch
A pitch built for in-licensing teams: TPP-aligned and competitively positioned.
- Positioned against the competitive landscape, not just describing the science
- Structured around what pharma and biotech in-licensing teams actually look for
- Suitable for partnering conferences, investor meetings, and email outreach
Run targeted outreach and secure meetings
We reach out to the right-fit companies on your behalf, or hand you the list to run yourself.
- Relevant in-licensing contacts selected by role and in-licensing activity
- All correspondence copied into a shared folder so you have full visibility
- Follow-up rounds managed for you, because that is where most outreach stalls
Maximise partnering events without the overhead
We attend 4+ major conferences a year, including BIO and BIO-Europe, and handle meetings on your behalf.
- Active representation: we secure one-on-one meetings for your asset
- Passive option: we upload your profile and report on inbound interest
- Conference and travel costs shared across clients to keep costs low
End-to-end negotiation and deal close
We coordinate term sheets, diligence, and contracting, keeping both sides moving toward close.
- Negotiations and diligence coordinated so nothing falls between the cracks
- Data room setup and management handled if needed
- Hand off as much or as little as you need, on an hourly basis, no minimum commitment
Most outreach stalls during follow-up, not the first email. We manage every round to keep it moving.
How we work versus going it alone
What running a partnering process with internal resource costs you, versus engaging JustPartnering.
| Factor | On your own | With JustPartnering |
|---|---|---|
| Cost model | No upfront cost, but significant internal time diverted from R&D. | Hourly. No retainer, no success fees, no minimum commitment. |
| Timeline | No defined process: momentum depends on whoever has spare capacity that week. | Every viable partner approached in parallel, with follow-up managed throughout, so momentum never depends on spare capacity. |
Trusted by biotech and pharma teams worldwide.
- 50+
- Candidates progressed from lab to clinic
- 19+
- Years of partnering experience
Common questions
When is the right time to start a partnering process?
What do pharma companies look for when in-licensing?
How long does a biotech out-licensing process take?
What materials do I need for a biotech partnering process?
How do biotech licensing deals work?
Ready to move your asset forward?
Talk to a senior advisor about your asset and what partnering could look like. No brief required, just tell us where you are stuck.
Let’s Talk